Michael Fisch
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Michael Fisch
Jun 20, 2024, 01:37 |
Insight
Torrie Fields: Let’s make supportive cancer care the standard of care
Torrie Fields, Founder and Chief Executive Officer at TFA Analytics, shared a post by Ramy…
Jun 3, 2024, 13:20 |
Societies
Julia Lai-Kwon: Still buzzing from our ASCO24 session on Integrating PROs in routine care
Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…
Jun 1, 2024, 14:46 |
Societies
15 Posts From ASCO24 Day 1 You Should Not Miss!
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is being held from May…
Apr 8, 2024, 08:14 |
Blog
Allison Rosen: It is a true honor and privilege to serve as the AYA research advocate
Allison Rosen, Director of Project ECHO at American Cancer Society, shared on X/Twitter: "Missing a…
Oct 4, 2023, 17:14 |
Insight
Ramy Sedhom: New editorial led by Kathryn DeCarli and ft ASCO Jamie Von Roenn!
Quoting Ramy Sedhom, Medical Oncologist and Palliative Care Physician at Penn Medicine, University of Pennsylvania…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube